Evidence map›Paper›PMID 30953176›Full record

Trial reportEuropean journal of applied physiology2019

Impact of 8 weeks of repeated ischemic preconditioning on running performance.

Joshua T Slysz, Jamie F Burr

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of applied physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joshua T SlyszDepartment of Human Health and Nutritional Sciences, University of Guelph, ANNU Building, 50 Stone Rd East, Guelph, ON, N1G 2W1, Canada.
Jamie F BurrDepartment of Human Health and Nutritional Sciences, University of Guelph, ANNU Building, 50 Stone Rd East, Guelph, ON, N1G 2W1, Canada. burrj@uoguelph.ca.

Funding

Canada Foundation for Innovation 460597Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada 03974Mitacs Grant IT05783
6 · The paper itself

Abstract

purposeTo examine if repeated exposure to IPC treatment prior to training sessions improves oxygen uptake and 1-km running performance in highly trained middle-distance runners.

methodsFourteen highly trained endurance runners (11 male/3 female, 19 ± 2 years, 64 ± 5 ml kg

results[Formula: see text] did not increase from baseline in either group following the 8-week training bout (P = 0.2), and neither group varied more than the other ([Formula: see text] = IPC 0.6 ± 2 ml kg

conclusionOur data suggest that over a normal 8-week season in a population of highly trained middle-distance runners there is no benefit of undergoing chronic, repeated IPC treatments before training for augmenting maximal aerobic power or 1-km performance time.

Indexed as

Athletic PerformanceAdolescentFemaleHumansIschemic PreconditioningLegMaleOxygen ConsumptionPhysical Conditioning, HumanRunningYoung AdultExerciseHypoxiaIPCOcclusionRunning

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.